Market closed · Next open: Wednesday 9:30 AM ET
Last update: Nov 17, 2026, 6:19 PM ET
HCA Healthcare, Inc.
$501.19▼ 2.07% today
Market Closed

Why HCA Healthcare, Inc. (HCA) stock moved

No significant move on Nov 17, 2026 (−2.1%, close-to-close). Latest notable session: Nov 16, 2026.

Latest session▲ 2.6% · Nov 16, 2026 close

Why HCA Healthcare, Inc. (HCA) rose 2.6% on November 16, 2026

HCA Healthcare, Inc. (HCA) rose 2.6% on November 16, 2026, closing at $511.78 versus $499.05 the prior session (close-to-close, from daily closes). As part of a broader rotation into healthcare and defensive equities, according to wsj.com. Investors are shifting capital away from volatile technology sectors toward steadier healthcare operators, reflecting institutional rebalancing into large-cap hospital providers. Source: WSJ.

Updated
Prior close
$499.05
Nov 16, 2026 close
$511.78
Change (close-to-close)
+$12.73
+2.55%
As first detected · Nov 16, 2026, 9:52 AM ET

HCA Healthcare rose 2.75% to $512.79 as part of a broader rotation into healthcare and defensive equities, according to wsj.com. Investors are shifting capital away from volatile technology sectors toward steadier healthcare operators, reflecting institutional rebalancing into large-cap hospital providers.

What to watch next: HCA earnings scheduled for 2027-01-26 (consensus EPS estimate $8.15); monitor sector rotation sustainability and any analyst target adjustments.

Source: WSJ · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved HCA

  1. +10.3%Following Democrats' decisive midterm election victory, securing control of both the House and Senate. Read the November 4, 2026 analysis →
  2. +3.2%Following recognition of more than 100 of its hospitals by Healthgrades for excellence in specialty care, per Business Wire.
  3. +2.9%After reporting better-than-expected Q3 results today, prompting analysts to raise their forecasts, per Benzinga.
  4. −3.3%After reporting Q3 2026 results that beat consensus EPS by 8.57% ($7.22 vs. $6.65 estimate) and revenue of $19.85 billion (+3.6% year-over-year).
  5. +2.9%HCA moved +3.33% from its $421.59 open to a $435.61 close on 2026-09-25.
  6. −3.0%HCA moved -3.17% from its $437.36 open to a $423.48 close on 2026-09-24.
  7. +2.9%HCA moved +1.98% from its $429.63 open to a $438.12 close on 2026-09-22.
  8. +4.9%Following reassuring commentary from CEO Sam Hazen at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026.
  9. −2.8%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.

HCA Healthcare, Inc. (HCA) shares fell 2.1% to $501.19 as of November 18, 2026, a modest decline from the prior close of $511.78. BestStocks flagged the session as a major change for HCA. The move is tied to company news. Below, we break down what changed for HCA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Company News

HCA Healthcare earned seventh consecutive Military Times Best for Vets Employer recognition for veteran recruitment and support. Demonstrates HCA's talent acquisition strength and cultural commitment, supporting workforce stability and employee retention metrics.

This summary describes the catalyst and move as first detected on Nov 11, 2026, 10:18 AM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
NewsWeak confidence
Rel. volume
0.9×
Below Avg
Vs peers
—
No comparable peers
Market cap
$104.7B
New York Stock Exchange
Analyst target
$466
-7.0% vs price
Price chart
Oct 19 – Nov 18
NNVNNFVNVEVN$449$481$513Oct 19Oct 27Nov 3Nov 11Nov 18
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for HCA Healthcare, Inc. investors

For HCA Healthcare, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; HCA Healthcare rallied 6.05% to $413.18 following upbeat second-quarter earnings reported on July 27, according to Benzinga. Weighing against that: Negative session, down 2.1%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $466.26, implying -7.0% downside from $501.19. BestStocks rates the overall signal quality weak (36/100). With earnings roughly 69 days out, the next report is the most likely near-term test of the move.

HCA price reaction

HCA last traded at $501.19, down $10.59 (-2.07%) from the previous close of $511.78. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $449.96 and $511.78, and it currently sits about 83% of the way up that band.

Bullish and bearish analyst opinions on HCA Healthcare, Inc. (HCA)

The consensus analyst price target on HCA Healthcare, Inc. (HCA) is $466.26, 7.0% below the recent $501.19. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HCA line up.

The bullish case

  • The Street's most bullish target is $579.00 (+15.5%).
  • Positive price momentum.
  • HCA Healthcare rallied 6.05% to $413.18 following upbeat second-quarter earnings reported on July 27, according to Benzinga.

The bearish case

  • The consensus analyst price target of $466.26 sits 7.0% below the recent $501.19, so the average target sees limited room to run.
  • The most bearish analyst target is $369.00 (-26.4%).
  • Negative session, down 2.1%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 18, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $466-7.0%
= 13 maintains
Truist Securities maintained Buy · 2026-11-03
SEC filings watch
8-K2026-11-05
Material event — review for impact
high
8-K2026-11-02
Material event — review for impact
high
10-Q2026-10-29
Quarterly financial results
medium
8-K2026-10-27
Material event — review for impact
high
Peer context
HCA-2.1%

Previous notable changes for HCA

News2026-11-10-0.1%
Pomerantz Law Firm launched investor investigation into HCA Healthcare regarding unspecified claims.
Valuation2026-11-04+10.3%via investing.com ↗
HCA Healthcare surged 10.47% to $511.33 following Democrats' decisive midterm election victory, securing control of both the House and Senate. According to the web catalyst and corroborated by investing.com, cnbc.com, and morningstar.com, the rally reflects expectations that a Democratic-led Congress will reverse or delay Medicaid cuts and protect ACA marketplace funding — removing significant regulatory and reimbursement risks for hospital operators. Volume reached 1.7M shares (2.74x the expected intraday average), underscoring broad conviction in the move.
News2026-11-03-1.0%
Pomerantz Law Firm launched investor investigation into HCA Healthcare regarding unspecified claims.
News2026-11-02-1.2%
HCA subsidiary plans public offering of senior notes to raise capital.

In-depth HCA event analyses

Permanent, dated analyses of HCA's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2027-01-26 (est.)
in 69 days
10-Q Filing (est.)
2027-01-28
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Low
from change events

Frequently asked questions about HCA

Why did HCA Healthcare, Inc. (HCA) stock move?

HCA Healthcare, Inc. (HCA) rose 2.6% on November 16, 2026, closing at $511.78 versus $499.05 the prior session (close-to-close, from daily closes). As part of a broader rotation into healthcare and defensive equities, according to wsj.com. Investors are shifting capital away from volatile technology sectors toward steadier healthcare operators, reflecting institutional rebalancing into large-cap hospital providers. Source: WSJ.

How much did HCA stock fall?

HCA lost 2.07% ($10.59) versus the prior close of $511.78, last trading at $501.19 on 0.9× average volume.

When is HCA Healthcare, Inc.'s next earnings date?

HCA's next earnings report is estimated for 2027-01-26 — about 69 days away.

What is the analyst price target for HCA?

The consensus analyst price target for HCA is $466.26, about 7.0% below the current $501.19. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.

How BestStocks tracks HCA

This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for HCA, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 18, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataCompany news feedsSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.